Cargando…

Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology

OBJECTIVES: To assess the clinical and cost-effectiveness of human papillomavirus (HPV) primary screening triage with p16/Ki-67 dual stain cytology compared to cytology. METHODS: We conducted an Excel(®)-based budget impact model to estimate the preinvasive and invasive cervical cancer cases identif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Termrungruanglert, Wichai, Khemapech, Nipon, Tantitamit, Tanitra, Havanond, Piyalamporn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393632/ https://www.ncbi.nlm.nih.gov/pubmed/30740950 http://dx.doi.org/10.3802/jgo.2019.30.e17

Ejemplares similares

Cost-Effectiveness of Primary HPV Screening Strategies and Triage With Cytology or Dual Stain for Cervical Cancer
por: Tantitamit, Tanitra, et al.
Publicado: (2020)

A Model Approach for Assessing the Benefits of HPV Testing against Cytology in Screening for Cervical Cancer Precursors in Thailand
por: Tantitamit, Tanitra, et al.
Publicado: (2017)

Cost-effectiveness analysis study of HPV testing as a primary cervical cancer screening in Thailand
por: Termrungruanglert, Wichai, et al.
Publicado: (2017)

The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand
por: Termrungruanglert, Wichai, et al.
Publicado: (2021)

Value of CCNA1 Promoter Methylation in Triaging ASC-US Cytology
por: Oranratanaphan, Shina, et al.
Publicado: (2020)

p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening
por: Han, Qin, et al.
Publicado: (2020)

Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology
por: Mazurec, Karolina, et al.
Publicado: (2023)

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting
por: Kotaniemi-Talonen, L, et al.
Publicado: (2005)

The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening
por: Aitken, Clare A, et al.
Publicado: (2019)

Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki‐67 dual‐stained cytology—Retrospective insights from ATHENA
por: Stoler, Mark H., et al.
Publicado: (2019)

Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening
por: Harper, Diane M., et al.
Publicado: (2023)

Cervical Cancer Screening in Low Resource Settings: Cytology versus HPV Triage for VIA Positive Women
por: Mishra, Gauravi A., et al.
Publicado: (2019)

Triaging HPV-Positive Cervical Samples with p16 and Ki-67 Dual Stained Cytology within an Organized Screening Program—A Prospective Observational Study from Western Norway
por: Øvestad, Irene Tveiterås, et al.
Publicado: (2023)

Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial
por: Wright, Thomas C., et al.
Publicado: (2021)

Accuracy and Efficiency of Deep-Learning–Based Automation of Dual Stain Cytology in Cervical Cancer Screening
por: Wentzensen, Nicolas, et al.
Publicado: (2020)

Validation of HPV triage in cytology-based cervical cancer screening for ASC-US cases using Japanese data
por: Aoki, Eiko Saitoh, et al.
Publicado: (2022)

Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study
por: Uijterwaal, M H, et al.
Publicado: (2014)

Application of p16/Ki-67 dual-staining cytology in cervical cancers
por: Yu, Li, et al.
Publicado: (2019)

Triage of Women with Low-Grade Cervical Lesions - HPV mRNA Testing versus Repeat Cytology
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2011)

Liquid-Based Screening Tests Results: HPV, Liquid-Based Cytology, and P16/Ki67 Dual-Staining in Private-Based Opportunistic Cervical Cancer Screening
por: Trzeszcz, Martyna, et al.
Publicado: (2021)

Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
por: Ikenberg, Hans, et al.
Publicado: (2013)

Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing
por: Vassilakos, P, et al.
Publicado: (2002)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

Shifting from cytology to HPV testing for cervical cancer screening in Canada
por: Delpero, Emily, et al.
Publicado: (2022)

Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16(INK4a) immunostaining in China
por: Song, Fangbin, et al.
Publicado: (2021)

Cost-Effectiveness and Cost-Benefit of Cervical Cancer Screening with Liquid Based Cytology Compared with Conventional Cytology in Germany
por: Armstrong, Stephanie F, et al.
Publicado: (2020)

HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico
por: Flores, Yvonne N., et al.
Publicado: (2010)

HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study
por: Kelly, R S, et al.
Publicado: (2011)

Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme
por: Anttila, Ahti, et al.
Publicado: (2010)

Significance of Triple Detection of p16/ki-67 Dual-Staining, Liquid-Based Cytology and HR HPV Testing in Screening of Cervical Cancer: A Retrospective Study
por: Yu, Li, et al.
Publicado: (2022)

Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus–Based Screening in Mexico
por: Torres-Ibarra, Leticia, et al.
Publicado: (2019)

Thionin Stain Replacement of Toluidine Blue Stain for Cytological Specimen Triage Improves Safety during the COVID-19 Pandemic
por: Arpin, Ronald, et al.
Publicado: (2021)

HPV-specific risk assessment of cervical cytological abnormalities
por: Zhong, Guanglei, et al.
Publicado: (2021)

Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies
por: Pista, Angela, et al.
Publicado: (2019)

Performance of HPV16/18 in Triage of Cytological Atypical Squamous Cells of Undetermined Significance
por: Cao, Xiaoqin, et al.
Publicado: (2019)

Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate
por: Arbyn, Marc, et al.
Publicado: (2009)

p16(INK4a)/Ki-67 dual stain cytology for cervical cancer screening in Thika district, Kenya
por: Ngugi, Caroline Wangari, et al.
Publicado: (2015)

The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples
por: Song, Fangbin, et al.
Publicado: (2020)

14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology
por: Asciutto, Katrin Christine, et al.
Publicado: (2020)

Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study
por: Hanley, Sharon J.B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1sojfbt6cmhqdde3uf5glt50ih